On January 2, 2018 Rubius Therapeutics, a biotechnology company pioneering the creation of a new class of extraordinarily active, ready-to-use and life-changing cellular therapies, reported that David Epstein, executive chairman of Rubius, will provide a corporate presentation at the 36th Annual J.P. Morgan Healthcare Conference (Press release, Rubius Therapeutics, JAN 2, 2018, View Source [SID1234522866]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will take place at 7:30 a.m. PST (10:30 a.m. EST) on Monday, January 8, 2018 at the Westin St. Francis Hotel in San Francisco.